Make 2nds Count can help find a trial for you!
Make 2nds Count has relaunched its free clinical trials service, helping secondary breast cancer patients, including those with triple negative breast cancer, find suitable trials. This nurse-led support offers expert guidance and tailored searches.
Government Recognises That TNBC Needs A Specific Approach
Recently in parliament, government representatives recognised that a cancer specific approach is needed to meet the challenges in cancer care and to improve outcomes for people living with triple negative breast cancer.
Keytruda (Pembroluzimab) Positive Results!
Positive results have been shared by pharmaceutical company MSD from their recent trial with Keytruda, combined with chemotherapy, as a promising treatment for high-risk early-stage triple negative breast cancer patients
The UK Charity for TNBC Becomes NICE Stakeholder
The UK Charity for Triple Negative Breast Cancer is delighted to become a NICE stakeholder, contributing patient perspectives to the development of key breast cancer treatments.
The UK Charity for TNBC Appears on BOPA Podcast
Robin Woolcock, founder of the UK Charity for Triple Negative Breast Cancer, joins Michal Sladkowski on the Let's Talk About SACT podcast. He discusses his experience with TNBC, the motivation behind the charity, and the support available for patients and staff.